Pulse Biosciences EPS - Earnings per Share 2016-2025 | PLSE
Pulse Biosciences eps - earnings per share from 2016 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Pulse Biosciences Annual EPS | |
|---|---|
| 2024 | $-0.92 |
| 2023 | $-0.85 |
| 2022 | $-1.72 |
| 2021 | $-2.28 |
| 2020 | $-2.14 |
| 2019 | $-2.26 |
| 2018 | $-2.20 |
| 2017 | $-1.73 |
| 2016 | $-0.86 |
| 2015 | $-0.37 |
| Pulse Biosciences Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.25 |
| 2024-12-31 | $-0.33 |
| 2024-09-30 | $-0.21 |
| 2024-06-30 | $-0.20 |
| 2024-03-31 | $-0.18 |
| 2023-12-31 | $-0.18 |
| 2023-09-30 | $-0.19 |
| 2023-06-30 | $-0.22 |
| 2023-03-31 | $-0.26 |
| 2022-12-31 | $-0.21 |
| 2022-09-30 | $-0.49 |
| 2022-06-30 | $-0.44 |
| 2022-03-31 | $-0.58 |
| 2021-12-31 | $-0.51 |
| 2021-09-30 | $-0.48 |
| 2021-06-30 | $-0.58 |
| 2021-03-31 | $-0.71 |
| 2020-12-31 | $-0.53 |
| 2020-09-30 | $-0.51 |
| 2020-06-30 | $-0.53 |
| 2020-03-31 | $-0.57 |
| 2019-12-31 | $-0.65 |
| 2019-09-30 | $-0.57 |
| 2019-06-30 | $-0.55 |
| 2019-03-31 | $-0.49 |
| 2018-12-31 | $-0.51 |
| 2018-09-30 | $-0.64 |
| 2018-06-30 | $-0.54 |
| 2018-03-31 | $-0.51 |
| 2017-12-31 | $-0.55 |
| 2017-09-30 | $-0.52 |
| 2017-06-30 | $-0.43 |
| 2017-03-31 | $-0.23 |
| 2016-12-31 | $-0.20 |
| 2016-09-30 | $-0.21 |
| 2016-06-30 | $-0.23 |
| 2016-03-31 | $-0.22 |
| 2015-12-31 | $-0.13 |
| 2015-09-30 | $-0.10 |
| 2015-06-30 | $-0.08 |
| 2015-03-31 | $-0.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.024B | $0.001B |
| Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.593B | 80.41 |
| Thermo Fisher Scientific (TMO) | United States | $157.789B | 19.09 |
| Edwards Lifesciences (EW) | United States | $45.057B | 29.54 |
| Alcon (ALC) | Switzerland | $42.394B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $42.355B | 48.67 |
| DexCom (DXCM) | United States | $33.243B | 51.38 |
| IQVIA Holdings (IQV) | United States | $27.279B | 15.28 |
| Mettler-Toledo (MTD) | United States | $24.286B | 28.88 |
| STERIS (STE) | Ireland | $22.511B | 24.79 |
| Waters (WAT) | United States | $17.231B | 24.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.059B | 0.00 |
| Hologic (HOLX) | United States | $14.097B | 15.32 |
| Sysmex ADR (SSMXY) | Japan | $10.412B | 29.54 |
| Penumbra (PEN) | United States | $9.155B | 71.86 |
| Masimo (MASI) | United States | $8.677B | 32.01 |
| Globus Medical (GMED) | United States | $7.564B | 18.02 |
| Glaukos (GKOS) | United States | $5.615B | 0.00 |
| Teleflex (TFX) | United States | $5.014B | 8.28 |
| Integer Holdings (ITGR) | United States | $4.098B | 21.47 |
| TransMedics (TMDX) | United States | $3.913B | 85.06 |
| PROCEPT BioRobotics (PRCT) | United States | $3.210B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.368B | 14.10 |
| Nihon Kohden (NHNKY) | Japan | $2.008B | 23.03 |
| Veracyte (VCYT) | United States | $1.977B | 27.74 |
| Elekta AB (EKTAY) | Sweden | $1.869B | 16.81 |
| Alphatec Holdings (ATEC) | United States | $1.566B | 0.00 |
| Artivion (AORT) | United States | $1.332B | 124.76 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.912B | 4.85 |
| IRadimed (IRMD) | United States | $0.735B | 37.31 |
| SiBone (SIBN) | United States | $0.721B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.577B | 12.52 |
| Beta Bionics (BBNX) | United States | $0.543B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.534B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.534B | 8.30 |
| AxoGen (AXGN) | United States | $0.532B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.432B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.427B | 9.92 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.422B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.384B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.351B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.303B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.267B | 0.00 |
| Neuronetics (STIM) | United States | $0.247B | 0.00 |
| 908 Devices (MASS) | United States | $0.233B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.225B | 13.61 |
| Monogram Orthopaedics (MGRM) | United States | $0.211B | 0.00 |
| CVRx (CVRX) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.173B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.118B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.105B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| Spectral AI (MDAI) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 42.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 22.22 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.35 |